Chesham, United Kingdom

Lewis Reuben Canning


Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 71(Granted Patents)


Location History:

  • Herts, GB (1988)
  • Bucks, GB (1989)
  • Chesham, GB (1999)

Company Filing History:


Years Active: 1988-1999

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Lewis Reuben Canning

Introduction

Lewis Reuben Canning, a notable inventor based in Chesham, Great Britain, has made significant contributions to the field of radiopharmaceuticals. With a total of six patents to his name, Canning's work focuses on the development of metal chelating compounds that play a crucial role in medical applications. His inventions reflect a blend of scientific expertise and innovative thinking.

Latest Patents

Among his most recent patents, Canning has worked on metal chelating compounds featuring an SNNN donor set. These ligands have potential applications in radiopharmaceutical use, allowing for the efficient chelation of radiometal species. Furthermore, these compounds can be bound to biological targeting molecules, enhancing their efficacy. Specifically, the ligands possess a formula that includes variations of elements and compounds, ensuring their versatility in pharmaceutical formulations. Additionally, he has developed radiometal complexes that are capable of localizing in hypoxic tissue, showcasing his innovative approach to addressing complex medical challenges.

Career Highlights

Canning's career includes significant stints at Amersham International Plc and Nycomed Amersham Plc, where he has been instrumental in driving forward research in the field of radiopharmaceuticals. His expertise and inventiveness have positioned him as a leading figure in his domain, making lasting impacts on the industry through his inventive insights and advancements.

Collaborations

Throughout his career, Lewis Canning has collaborated with esteemed individuals such as Colin M Archer and Harjit Kaur Gill. These collaborations have fostered a productive exchange of ideas, enhancing the potential for innovation in their projects and furthering advancements in the field of medical research.

Conclusion

In summary, Lewis Reuben Canning stands out as a prominent inventor with a clear focus on innovations in radiopharmaceuticals. His latest patents highlight a commitment to advancing medical applications through his work on metal chelating compounds. With a diverse career and valuable collaborations, Canning continues to influence the field and pave the way for future discoveries in healthcare innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…